Conductive vancomycin-loaded mesoporous silica polypyrrole-based scaffolds for bone regeneration by Zanjanizadeh Ezazi, Nazanin et al.
 
 
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright 
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
 Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
 You may not further distribute the material or use it for any profit-making activity or commercial gain 
 You may freely distribute the URL identifying the publication in the public portal 
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
  
 
   
 
 
Downloaded from orbit.dtu.dk on: Apr 02, 2019
Conductive vancomycin-loaded mesoporous silica polypyrrole-based scaffolds for
bone regeneration
Zanjanizadeh Ezazi, Nazanin; Shahbazi, Mohammad-Ali; Shatalin, Yuri V.; Nadal, Eloy; Mäkilä, Ermei;
Salonen, Jarno; Kemell, Marianna; Correia, Alexandra; Hirvonen, Jouni; Santos, Hélder A.
Published in:
International Journal of Pharmaceutics
Link to article, DOI:
10.1016/j.ijpharm.2017.11.065
Publication date:
2018
Document Version
Peer reviewed version
Link back to DTU Orbit
Citation (APA):
Zanjanizadeh Ezazi, N., Shahbazi, M-A., Shatalin, Y. V., Nadal, E., Mäkilä, E., Salonen, J., ... Santos, H. A.
(2018). Conductive vancomycin-loaded mesoporous silica polypyrrole-based scaffolds for bone regeneration.
International Journal of Pharmaceutics, 536(1), 241-250. DOI: 10.1016/j.ijpharm.2017.11.065
Accepted Manuscript
Title: Conductive vancomycin-loaded mesoporous silica
polypyrrole-based scaffolds for bone regeneration
Authors: Nazanin Zanjanizadeh Ezazi, Mohammad-Ali
Shahbazi, Yuri V. Shatalin, Eloy Nadal, Ermei Ma¨kila¨, Jarno
Salonen, Marianna Kemell, Alexandra Correia, Jouni
Hirvonen, He´lder A. Santos
PII: S0378-5173(17)31120-1
DOI: https://doi.org/10.1016/j.ijpharm.2017.11.065
Reference: IJP 17185
To appear in: International Journal of Pharmaceutics
Received date: 10-10-2017
Revised date: 20-11-2017
Accepted date: 27-11-2017
Please cite this article as: Ezazi NZ, Shahbazi M-A, Shatalin YV, Nadal
E, Ma¨kila¨ E, Salonen J, Kemell M, Correia A, Hirvonen J, Santos HA,
Conductive vancomycin-loaded mesoporous silica polypyrrole-based scaffolds
for bone regeneration, International Journal of Pharmaceutics (2010),
https://doi.org/10.1016/j.ijpharm.2017.11.065
This is a PDF file of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that
apply to the journal pertain.
1 
 
Conductive vancomycin-loaded mesoporous silica polypyrrole-based 
scaffolds for bone regeneration  
 
Nazanin Zanjanizadeh Ezazi1, Mohammad-Ali Shahbazi1,2, Yuri V. Shatalin3, Eloy 
Nadal1, Ermei Mäkilä4, Jarno Salonen4, Marianna Kemell5, Alexandra Correia1, Jouni 
Hirvonen1, Hélder A. Santos1,6* 
 
1 Drug Research Program, Division of Pharmaceutical Chemistry and Technology, 
Faculty of Pharmacy, University of Helsinki, FI-00014 Helsinki, Finland 
2
 Department of Micro and Nanotechnology, Technical University of Denmark, 2800 
KGs.Lyngby, Denmark 
3 Laboratory of Tissue Engineering, Institute of Theoretical and Experimental Biophysics, 
Russian Academy of Science, Institutskaya 3, Pushchino, 142290 Moscow Region, 
Russia 
4 Laboratory of Industrial Physics, Department of Physics and Astronomy, University of 
Turku, FI-20014 Turku, Finland 
5 Department of Chemistry, University of Helsinki, FI-00014 Helsinki, Finland 
6 Helsinki Institute of Life Sciences (HiLIFE), University of Helsinki, FI-00014 Helsinki, 
Finland 
 
*Corresponding author:  
E-mail: helder.santos@helsinki.fi; Tel.: +358 2941 59661. 
 
 
Graphical abstract 
AC
CE
PT
ED
 M
AN
US
CR
IPT
2 
 
 
 
Abstract  
Bone tissue engineering is considered an alternative approach for conventional strategies 
available to treat bone defects. In this study, we have developed bone scaffolds composed 
of hydroxyapaptite (HAp), gelatin and mesoporous silica, all recognized as promising 
materials in bone tissue engineering due to favorable biocompatibility, osteoconductivity 
and drug delivery potential, respectively. These materials were coupled with conductive 
polypyrrole (PPy) polymers to create a novel bone scaffold for regenerative medicine. 
Conductive and non-conductive scaffolds were made by slurry casting method and loaded 
with a model antibiotic, vancomycin (VCM). Their properties were compared in different 
experiments in which scaffolds containing PPy showed good mechanical properties, 
higher protein adsorption and higher percentage of VCM release over a long duration of 
time compared to non-conductive scaffolds. Osteoblast cells were perfectly immersed 
into the gelatin matrix and remained viable for 14 days. Overall, new conductive 
composite bone scaffolds were created and the obtained results strongly verified the 
applicability of this conductive scaffold in drug delivery, encouraging its further 
development in tissue engineering applications. 
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1. Introduction  
Tissue engineering coupled with drug delivery plays a novel key role in the treatment of 
various diseases through the combination of materials science, biomedical engineering 
and pharmaceutical sciences (Cui et al., 2010; Hu et al., 2014). Tissue engineering can 
create a useful ground in which the new tissue can be regenerated in a short period of time 
with high efficiency. Bone tissue engineering has been extensively studied in recent years 
in order to overcome the bone defects known as a common clinical problem (El-
Ghannam, 2005; Zhou et al., 2014). It introduces new approaches to replace the previous 
methods, such as autografts and allografts, which result in second operation at tissue 
harvest site, high cost, serious infection and morbidity (Amini et al., 2012). The 
engineered bone scaffolds are known as an important approach in repairing the structure 
and physiological function of damaged bone by their porous 3D-structures, which allow 
regenerating the new bone cells and permit nutrient flow via its interconnections, 
increasing the chance of treating bone damage (Hollister, 2005). To achieve this goal, it 
is essential for scaffolds to show suitable osteoconductivity, cell adhesion, degradation, 
bioactivity and low cytotoxicity (Hu et al., 2014; Ronca et al., 2013). As their main 
function, scaffolds afford the initial and temporary mechanical stability of the bones and 
let the cells to proliferate inside the pores to make the new tissue; meanwhile the scaffold 
gradually starts to degrade and create free space for the new cells (Berthiaume et al., 
2011). 
Synthetic hydroxyapatite (HAp) is widely used in bone tissue engineering due to its 
similar chemical composition to the inorganic HAp in bone (Jones R H, 2013). 
Biocompatibility, osteoconductivity, good chemical bone-bonding ability, as well as 
supporting and promoting the bone regenerative process make this ceramic an ideal 
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component of bone scaffolds (Lewandowska-Lancucka et al., 2015; Rezaei and 
Mohammadi, 2013). HAp implant systems prevent bacterial pathogens growth (Carlson 
et al., 2004), while helping to improve osteoblast differentiation. Nevertheless, poor 
mechanical properties and low degradation rate are the main drawbacks, which demand 
other materials, such as polymers, other ceramics, or natural phases to be combined to 
improve the HAp properties (Lewandowska-Lancucka et al., 2015; Rezaei and 
Mohammadi, 2013). 
Silica, for example, with the high potential to induce the mineralization process and 
improve cell viability, can be a supplement for calcium phosphate (CaP) based systems 
to facilitate osteoblast cell regeneration (Fwu-Hsing Liu et al., 2011; Heinemann et al., 
2011; Lewandowska-Lancucka et al., 2015). In addition, mesoporous silica can be 
considered as a drug delivery vehicle with controlled release properties, due to presence 
of silanol groups that facilitate the surface functionalization/coating of the particles 
(Boccardi et al., 2015; Fussell et al., 2014; Heikkila et al., 2010; Kinnari et al., 2011; 
Limnell et al., 2011a; Limnell et al., 2011b; Zhang et al., 2013). The promising 
biocompatibility, thermal and chemical stability, low toxicity,  and promoting osteoblast 
cell activity make mesoporous silica a worthy candidate in bone tissue regeneration 
purposes (Shadjou and Hasanzadeh, 2015).  
Another candidate in bone tissue engineering is gelatin, which has been mostly studied 
and is widely incorporated with CaP compositions (Bigi et al., 2004). Gelatin is known 
as a natural biodegradable polymer with high water solubility and biocompatibility, which 
is able to increase the pore size and improve the workability and mechanical properties 
of the bone cement (Bigi et al., 2004; Shie et al., 2008). In general, natural bone 
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microstructure can be mimicked by a remarkable surface area and interfacial interaction 
between HAp and gelatin (Chiu et al., 2015).  
In biomaterials science, materials with specific properties are used in order to present 
smart behavior in regeneration treatment. For example, polypyrrole (PPy), is a conductive 
polymer which is mostly used in smart biomedical composites together with other 
biomaterials, such as alginate, especially where the conductivity is a major interest of the 
scaffold properties to stimulate the cell proliferation (Sajesh et al., 2013). PPy has a good 
electrical conductivity, which is due to p-type conduction, the electrons inter-chain 
hopping and the anions or cations motion (Balint et al., 2014). It has electric and thermal 
stability, while it suffers from brittleness, poor mechanical and non-biodegradable 
properties (Sajesh et al., 2013; Yu et al., 2013). However, incorporating PPy with other 
materials can be a strategy to overcome these drawbacks. It has been shown that the PPy 
based composite bone scaffolds can be a new generation of scaffolds with high potency 
to create CaP on their surface (Jiang et al., 2005). 
There are studies suggesting a desirable differentiation of the cells in the presence of 
gelatin and HAp, with high alkaline phosphatase (ALP) and osteocalcin activity, and 
suitable ability to carry and release different drugs (Kim et al., 2005; Liu et al., 2009). 
Also, combination of chitosan, gelatin and SiO2 with fibrin coating or alginate and HAp, 
has already been shown acceptable mechanical properties, cell viability, and drug 
delivery properties (Kavya et al., 2013; Yan et al., 2016). Nevertheless, novel 
combination of conductive polymers with drug delivery properties is still missing in the 
previous studies. In addition, in many studies, mechanical strength of the scaffolds is not 
in the cancellous bone range, which has a compressive strength of 2−12 MPa and Young’s 
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modulus (E) of 0.05−0.5 GPa (Nicoll, 2011) , and they only can be used for short term 
drug delivery.  
In this study, we created a new class of composite bone scaffolds for prolonged drug 
delivery, by employing PPy (conductive polymer), gelatin (with remarkable ability to 
induce cell attachment), HAp (as the inorganic component of the bone) and vancomycin 
(VCM; antibiotic drug)-loaded mesoporous silica microparticles (for anti-infection 
effect). This way we hypothesize that the chosen materials may enhance the properties of 
each other and create a novel conductive scaffold to accelerate bone regeneration and 
simultaneously releasing the antibiotic for prolonged release, which excitingly pave new 
ways for the applications and further translation in future clinic setups. 
 
2. Materials and methods 
2.1. Materials 
Gelatin, HAp, PPy and glutaraldehyde solution (25 wt.-% in H2O) were purchased from 
Sigma-Aldrich. Mesoporous silica (SYLOID® 244 FP) was kindly provided by Grace 
Davison, and vancomycin hydrochloride (VCM) was obtained from BioChemica Inc. The 
chemicals NaCl, KCl, NaHCO3, NaSO4, Tris-buffer, glycerophosphate, ascorbic acid, 
dexamethasone, sodium dodecyl sulfate (SDS), dimethylsulfoxide (DMSO), 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) were purchased from Sigma-
Aldrich; K2HPO4·3H2O and CaCl2 were purchased from Merck Millipore. MgCl2·6H2O 
and HCl 1 M were obtained from Riedel-de Haën and VWR, respectively.  Phosphate 
buffered saline (PBS) 10×, fetal bovine serum (FBS), Dulbecco's Modified Eagle 
Medium (DMEM), L-glutamine, non-essential amino acids (NEAA) and penicillin 
streptomycin were purchased from HyClone, USA. Hank's Buffered Salt Solution 
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(HBSS) 10× was obtained from Gibco Life Technologies, CellTiter-Glo reagent was 
purchased from Promega Corporation, USA and the Micro-BCA protein assay kit was 
obtained from Thermo Fisher Scientific.  
 
2.2. Preparation of conductive composite scaffold 
Scaffolds were made by solvent casting method on ice (Shahini et al., 2014). In brief, 
samples were fabricated by adding a mixture of highly viscose HAp and mesoporous 
silica (10% w/v, each) water-base suspension into 2 ml of melted gelatin solution (1 
g/mL) and warmed in a water bath at 60 °C. PPy (0.26% w/v) was dispersed in water, 
sonicated and then added to the HAp-mesoporous silica-gelatin mixture. The suspension 
was then vortexed vigorously to obtain a homogenous slurry. Next, the slurry was casted 
into 24-well plates on an icebox under shaking conditions, followed by immediate 
freezing to −20 °C. Samples were freeze-dried by Heto LyoPro 3000 (Heto-Holten A/S, 
Denmark) at −50°C for 48 h to remove the water and create a porous scaffold. Later, the 
obtained scaffolds were crosslinked by 8% glutaraldehyde in water for 3 h to attach the 
components (HAp, silica and polyppyrrole) on gelatin matrix. Finally, the obtained 
scaffolds were washed with water and ethanol and freeze-dried for 6 h (Figure 1A). Two 
sets of scaffolds were made with this procedure: samples with PPy (+P) and their 
counterparts without PPy (-P). 
 
2.3. Scaffold properties  
The scaffold’s cross-section morphology was examined by scanning electron microscopy 
(SEM; FEI Quanta FEG250). The specific surface area of the scaffolds was evaluated 
with the Brunauer–Emmett–Teller (BET) method using nitrogen sorption at −196 °C 
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(TriStar 3000, Micromeritics Inc.) (Zhang et al., 2013). In addition, the porosity was also 
determined by liquid replacement method. For this, cuboid scaffolds (50−125 mg) were 
immersed in ethanol  (20 mL/sample) and degassed by reducing the pressure within a 
vacuum chamber to allow the ethanol to run through the pores of the scaffolds for 15−20 
min, until no air bubbles could be observed. Finally, the sample weight as immersed was 
recorded. The porosity of scaffolds was calculated by considering the volume of the pores 
(Vpores) and volume of cuboid scaffolds (Vscaffold), following Eqs. 1 and 2 (Shahini et al., 
2014): 
Vpores = m1-m0 / ρEtOH       (1) 
Porosity = (Vpores  / Vscaffold) × 100                           (2) 
where, m0 is the dry weight and m1 is the weight of the samples after the immersion in 
ethanol, while the ρEtOH is the density of the ethanol.   
 
2.4. Physicochemical characterization 
The scaffolds were ball-milled by Pulverisette 7 (Fritsch) at 19g for 10 min with zirconia 
balls (diameter: 10mm), in dry condition, to obtain a fine powder of each type of samples. 
Simultaneous thermogravimetric and differential scanning calorimetry (TG/DSC) 
measurements were done with STA 6000 (PerkinElmer) under a 60 ml/min flow of 
synthetic air using a temperature ramp of 20 °C/min. The chemical structure of the 
scaffolds was studied with Fourier transform infrared (FTIR) spectroscopy, using a 
Vertex 70 spectrometer (Bruker Optics) equipped with a MIRacle horizontal attenuated 
total reflectance accessory (Pike Technologies Inc.). The scans were done using a 
resolution of 4 cm-1.  
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2.5.Mechanical properties 
Mechanical properties of samples were measured and analyzed with a Lloyd LRX (Lloyd 
Instruments) at room temperature. New set of samples were made in a 2.5 mL syringe as 
a mold to obtain a cylindrical shape scaffold. They were lyophilized for 48 h at −50 °C 
and then were cut to 6 mm in diameter and 12 mm in length. The components were 
crosslinked together by 8% glutaraldehyde in water and freeze-dried for 6 h at −50 °C. 
The strength of the samples were tested under vertical force at the cross-section of 
cylinders with 1.5 mm/min speed and 1000 N maximum load, until they fractured. The 
compression strength and elastic modulus of three samples of both types were calculated 
from stress-strain curve plotted by the obtained data from the device (Arifvianto et al., 
2017).   
2.6. Swelling ratio measurements 
Swelling ratio was evaluated in order to examine the water absorption in two different 
types of scaffolds in aqueous solution. In addition, the influence of PPy in swelling ratio 
was studied. The samples were immersed in 1× PBS (pH=7) at 37 °C for 7 days (Sajesh 
et al., 2013) . On each time point (day 1, 4 and 7), each scaffold was taken out of the 
buffer, tapped on the filter paper to remove the water on the surface and weighed to obtain 
the wet weight. The swelling ratio was calculated using Eq. 3 (Sajesh et al., 2013): 
Swelling ratio = (mwet - mdry) / mdry      (3) 
where, the mwet is the weight of samples after the incubation in 1× PBS buffer and mdry 
is the initial weight before immersing in PBS.  
 
2.7. Biomineralization  
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In vitro acellular biomineralization on the surface of the scaffold’s pores was examined 
by immersing the scaffolds in 5 times saturated simulated body fluid (SBF(5)) solution 
containing NaCl, NaHCO3, KCl, K2HPO43H2O, MgCl26H2O, HCl 1 M, CaCl, NaSO4, 
and Tris-buffer at 37 °C for 21 days (Cai et al., 2011). The composition was similar to 
ions concentration in human plasma and it provides a suitable environment to create 
apatite crystals in vitro (Saravanan et al., 2013). At each time point, the samples were 
washed carefully with water and freeze-died. The formation of calcium crystals and their 
morphology were analyzed with a field emission SEM (Hitachi S-4800, Department of 
chemistry). The Ca:P ratios were measured using an Oxford INCA 350 energy-dispersive 
X-ray spectrometer (EDX) connected with the Hitachi S-4800. 
 
2.8. Protein adsorption measurements  
Protein adsorption is the first phenomena after scaffold implantation, which facilitates the 
cell attachment. Therefore, scaffolds need an initial amount of proteins on the surface for 
subsequent cell attachment (Dong et al., 2015). For the protein adsorption study, samples 
were washed with ethanol for 1 h under shaking, followed by further washings with PBS. 
PBS+10% FBS solution was added to each sample and incubated for 4, 14 and 24 h at 
37°C. Afterwards, samples were tapped by filter paper and washed again with PBS to 
eliminate the loosely attached FBS. The adsorbed protein was recovered by 2% SDS and 
the quantitative protein adsorption was detected by Micro-BCA protein assay kit (Thermo 
Scientific), following the protocol provided by the manufacturer (Woo et al., 2007). The 
different sets of scaffolds were treated with FBS in the same way, washed with water, and 
the morphology and protein attachment was analyzed with SEM (FEI Quanta FEG250). 
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2.9. Drug loading and release studies 
Mesoporous silica (Syloid® 244 FP) microparticles (1 g) were dispersed in 5 mg/mL of 
VCM in water for 3 h at room temperature. The drug-loaded mesoporous silica 
suspension was then centrifuged at 4020g for 7 min and the supernatant examined by UV-
Vis spectrophotometer (UV-1600(PC), VWR) to detect unloaded drugs. HAp suspension 
was added to the drug-loaded microparticles in the same ratio as explained in section 2.2, 
and thereafter, they were added to the falcon tubes containing melted gelatin followed by 
adding sonicated PPy and pouring everything in 24-well plates by the slurry casting 
method (Shahini et al., 2014). Next, samples were freeze-dried for 48 h in −50 °C to 
remove the solvent, and afterwards, the components were crosslinked on the gelatin 
matrix with 3 mL of 8% glutaraldehyde in water. The scaffolds were then washed 
carefully10 times (9 times in water and 1 time in ethanol) and freeze-dried for 6 h. About 
1 ml of the supernatant of each step of washing was examined by UV-Vis 
spectrophotometer at the wavelength of 229 nm to check the accumulative release of drug 
during each washing step. The release of VCM from the +P and -P scaffolds (weight 
average 1.7 and 1.5 g, respectively) was tested at 37 °C in 3 mL of PBS at different time 
points for 4 months. At each time point, 1 mL of the medium was taken out of the each 
sample and an equal volume was replaced to maintain the final release volume constant. 
The release of VCM was studied using a UV-Vis spectrophotometer at the wavelength of 
229 nm for each sample in quadruplicate.  
 
2.10. Cell studies 
K7M2WT (ATCC® CRL2836™) osteoblast cells were purchased from ATCC for the in 
vitro studies. Cells were cultured in DMEM medium supplemented with 10% FBS, 1% 
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L-glutamine, 1% NEAA and 1% (100×) penicillin streptomycin (purchased all from 
HyClone). They were kept in incubator (16 BB gas, Heraeus Instruments GmbH) in 
atmosphere of 5% CO2 and 95% relative humidity and passages used were between 9 and 
20 at confluency of ca. 80%. All the scaffolds used for cell studies were sterilized with 
ethanol for 1 h and then treated with UV-radiation for 1.5 h for each side. 
 
2.11. Cell viability  
ATP-luminescent was measured by CellTiter-Glo luminescent cell viability assay 
(Promega Corporation, USA) in order to test the cytotoxicity of scaffold’s degradation by 
extract method for 14 days (Frewin Ch et al., 2016). Prior to the test, scaffolds were 
immersed in DMEM + 10% FBS and antibiotics for each time point (5 time points, 4 
replications) at 37 °C in 5% CO2. Also, the medium (DMEM+10% FBS) was incubated 
in the same condition for 14 days as the blank medium. About 35,000 osteoblast K7M2 
cells were seeded in fresh DMEM + 10% FBS in each well in 96-well plate for 24 h. At 
each time point (day 1, 3, 5, 7 and 14) the medium of each well, containing cells, changed 
with scaffold’s and blank medium and incubated for 48 h. After, each sample (+P. -P and 
blank medium), and positive control containing fresh DMEM + 10% FBS and negative 
control 1% Triton X-100 were washed with buffered salt solution HBSS−HEPES pH 7.4 
and followed by addition of the CellTiter-Glo reagent. The samples were kept in dark on 
the shaker for 2 min and the lysed cells luminescence were measured by Varioskan Flash 
plate reader (ThermoFisher) within 15 min (Mori et al., 2014). 
 
2.12. Cell attachment 
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The cell morphology and attachment on each type of samples was tested by SEM. First, 
the samples were immersed in DMEM +10% FBS for 24 h. About 10 000 cells were then 
counted and added to each well in 24-well plates, followed by medium replacement every 
2 days. At each time point (day 1, 7, 14 and 21), the samples were taken out of the culture 
medium, washed with PBS (pH 7.4) three times and fixed by 2.5% glutaraldehyde in PBS 
at 37 °C for 1 h. Post-fixation of the samples was then performed using 0.5% osmium 
tetroxide in PBS for 1.5 h. Thereafter, different concentrations of ethanol (50, 70, 96 and 
100%) were used to dehydrate the cells. The samples were then coated with gold-
palladium alloy/platinum and analyzed with SEM (FEI Quanta FEG250). 
 
2.13. Statistical analysis 
The results are expressed as mean ± standard deviations (S.D.) of at least three 
independent set of measurements. Statistical analysis was achieved by means of one-way 
analysis of variance (ANOVA) with the level of significance set at probabilities of *p < 
0.05, **p < 0.01, ***p < 0.001, analyzed with OriginPro8.6 software. 
 
3. Results and discussion 
3.1.  Physicochemical characterization of the scaffolds 
The cross-section of the composite scaffolds was studied by SEM in order to investigate 
the structure and morphology of the pores created during the preparation of the scaffolds. 
As it can be seen in Figure 1B, freeze-drying of the casted scaffold created interconnected 
macroporous structures, composed of gelatin as the backbone matrix and nano-HAp (blue 
arrows) and mesoporous silica microparticles (green arrows) embedded on the surface, 
which is also demonstrated in detail with EDX studies in Figures S1–S3. The 
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characteristics of HAp nanoparticles has been already published by the manufacturer, 
Sigma-Aldrich. It has a molecular weight of 502.31 g/mol, particle size of ≤ 200nm and 
specific surface area of ≥ 9.4 m2/g (A.G. Osorio et al., 2011). As we reported previously 
(Kinnari et al., 2011), SYLOID® 244 FP have a particle size of 2.5−3.7 µm, a surface area 
of 311 ± 14 m2/g, a pore volume of 1.42 ± 0.04 cm3/g and an average pore diameter of 
19.0 ± 1.1 nm (Kinnari et al., 2011). In the +P scaffolds containing PPy, we can see the 
web-like PPy (red arrows) in the structure attaching on the matrix. The pore size of the 
scaffolds was analyzed by Image J 1.47v, ranging from 200 to 350 µm with average 
diameter size of 281 µm. Macrosized pores with HAp particles provide good locations 
for cell attachment and bone ingrowth (Sharma et al., 2016). The specific surface area 
and density evaluations showed higher area for the +P scaffolds (5.5 ± 0.1 m2/g) 
compared to the -P counterpart (2.7 ± 0.1 m2/g), while the densities of the +P (0.49 ± 0.05 
g/cm3) and -P (0.48 ± 0.21 g/cm3) samples were quite similar. The porosity value of +P 
was 86.0±1.2 % and for -P was 74.0±2.1 %. The results of the specific surface area and 
porosity indicate that +P samples showed larger pores (higher porosity) with more 
irregular pore walls (larger surface area). Moreover, the web-like fibers of PPy on the 
structure of the scaffolds are suitable locations for the attachment of molecules, cells or 
particles. 
 
3.2. Powder characteristics 
The FTIR spectra obtained from the powdered +P and -P scaffolds are shown in Figure 
1C. The distinct features of the spectra can be assigned in the presence of HAp and 
mesoporous silica in the composite, as the strong absorbance bands related to the 
phosphate groups of HAp were observed at 960, 1030 and 1085 cm-1 (Rehman and 
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Bonfield, 1997) superimposed with the silica ν(Si-O-Si) band at 795 cm-1 and the broad 
band between 1000–1200 cm-1, indicating Si−O stretching (Lippincott et al., 1958). 
Adjacent band are from the gelatin amide bands around 1640 and 1530 cm-1 with an 
absorbance band at 1345 cm-1 that can be assigned to Ca–COO vibrations, indicating 
chemical binding between the gelatin and HAp (Azami et al., 2010). There is practically 
no discernible difference between the spectra of +P and -P scaffolds, as the possible PPy 
related bands are masked by the gelatin bands.  
Thermal analysis was performed to study the influence of PPy on thermal properties of 
the scaffolds (Figure 1D). The results of the TGA and DSC scans are shown in Figure 
1D, which show similar behavior of both +P and -P scaffolds. The TGA/DSC curves 
show in both samples an initial weight loss accompanied by an endotherm, due to the 
drying of the sample. The TGA curves continue by the degradation and burning of the 
organic components, associated with the respective broad DSC endo- and exotherms for 
the thermal events. Total mass loss can be observed at 800−900 °C, which is 53.2 ± 0.5 
w-% and 53.6 ± 0.2 w-% for +P and –P, respectively, showing that the addition of PPy 
does not change the behavior of the scaffold under the temperature ramp.  
 
3.3. Mechanical properties 
Lloyd instrument was used in order to measure and analyze the (E) of the +P and -P 
scaffolds, by forcing the load (1000 N maximum) to the base surface area until the 
scaffolds were broken. Mechanical strength is one of the important factors in bone tissue 
engineering due to the bone function in human body, and this parameter indicates the 
force threshold which can be applied on the scaffolds before fracture. E value was 
calculated from the slope of linear stress-strain curve (Figure 2). Figure 2A shows that 
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both scaffolds had quite similar mechanical characteristics. The -P scaffolds showed 8 
MPa compression strength and Young’s modulus of 0.125 GPa, and the +P scaffolds 
showed almost the same values of 7 MPa compression strength with Young’s modulus of 
0.11 GPa, which was due to the low mechanical properties of PPy polymer. In addition, 
+P samples were more porous and less dense, which decreased the compression strength. 
In general, PPy did not decrease the compression strength of the composite scaffold and 
the combination of the materials showed a similar behaviour as reported in cancellous 
bone property (Nicoll, 2011), which is due to the crosslinking function of glutaraldehyde 
(8%) used for the amine-aldehyde reaction and the stability enhancement.  
 
3.4. Swelling ratio studies 
Swelling ability is an important factor in bone tissue engineering. Scaffolds need to be 
able to adsorb body fluids and make a proper place for nutrient flow and waste removal 
(Venkatesan et al., 2012). Therefore, the PBS absorption of the +P and -P sample were 
evaluated at 37 °C during 7 days (Sajesh et al., 2013). As shown in Figure 2B, after 24 h 
of immersion in the buffer, the scaffolds absorbed water more than their initial weight 
and the swelling ratio increased to higher than 100%. Both samples showed an increase 
in swelling ratio in 7 days. These results suggest a high hydrophilic behavior of the 
scaffolds, which is an important property for absorbing water to increase the size of the 
structure (pores), without changing the morphology. Here, the stability of the scaffold is 
due to the HAp particles (Im et al., 2012). Swelling can facilitate the migration and 
infiltration of the cells, as well as the diffusion of the nutrients (Saravanan et al., 2013; 
Sharma et al., 2016). However, the results also indicate that the scaffold containing PPy 
in its structure had slightly lower swelling ratio compare to the -P samples, which is 
AC
CE
PT
ED
 M
AN
US
CR
IPT
18 
 
probably due to the hydrophobicity of this polymer (Sajesh et al., 2013), and also due to 
the fact that +P scaffolds have high porosity, thus there is less mass to swell in a constant 
volume. Silica particles are hydrophilic as a result of the silanol groups on its surface 
(Kinnari et al., 2011). Also, gelatin as a reversible or thermoplastic polymer, which is 
hydrophilic, has high tendency to swell in higher temperature, while apatite shows lower 
water uptake due to HAp ceramic nature, making the structure more stable. The 
interaction between gelatin and HAp make a bond with appropriate swelling and stability 
properties at the same time (Bundela and Bajpai, 2008; Sharma et al., 2016). 
 
3.5. Biomineralization  
CaP crystals [Ca3(PO4)2] can facilitate the attachment of the osteoblast cells on the 
scaffold and trigger their differentiation (Saravanan et al., 2013). In this test, acellular 
biomineralization capability of scaffolds was carried out in vitro over 21 days in SBF(5). 
Scaffolds containing hydroxyapatite provide easy nucleation sites for the formation of 
new spherical crystals (Saravanan et al., 2013). The very first crystals of CaP were 
detected on day 7 in +P samples, and over time more crystals were observed on the surface 
of the scaffolds (Figure 3). On days 10 and 14, both samples (+P and -P) were covered 
by multiple layers of CaP, which was also confirmed by the main peaks of Ca and P 
detected by EDX analysis (Figure 3). Although CaP almost coats the entire surface, there 
were still some pores visible on the surface of the scaffolds. These non-confluent layers 
eventually merged and completely covered the surface on day 21 for both types of 
samples, as shown in Figure 3.  
The Ca:P ratio was evaluated also by SEM−EDX, showing values of 1.25−1.4 for both 
types of scaffolds, while the control (samples before immersion into SBF(5)) had a Ca:P 
ratio of 1.7. This range of ratio belongs to different type of CaP compositions. 
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Octocalcium phosphate have Ca:P ratio of 1.33, precipitated hydroxyapatite Ca:P ratio is 
1.33–1.67 and precipitated amorphous calcium phosphate (ACP) Ca:P ratio is 0.67–1.50 
. The metastable compositions of Ca:P, ACP for example, is an intermediate that can 
change to the more stable composition of apatite and reach a Ca:P ratio of 1.67 (Habraken 
et al., 2016; Zhao et al., 2011). As shown in Figure 3, Ca, P and Si were the main peaks 
in spectrum of control samples for +P and −P scaffolds. Compared to -P scaffolds, the Si 
peak decreased for +P samples in day 7, while the Ca and P peaks increased. These results 
are in line with our observation in SEM study and confirm the ability of our fabricated 
conductive scaffold to form apatite in a short time period as compared to the non-
conductive scaffold. The Si peak completely disappeared at day 10 as the apatite layer 
coated the surface of the pores. The formation of CaP crystals indicates the surface 
bioactivity of both scaffolds and their ability to absorb PO4
3− and Ca2+ due to the electrical 
charges of the surface. Moreover, the silanol groups of the mesoporous silica 
microparticles can attract Ca2+ and create a positive layer on the surface, which can then 
adsorb PO4
3- and make the apatite to grow (Yazdimamaghani et al., 2015).  
 
3.6. Protein adsorption 
Protein adsorption is a crucial step that occurs right after the implantation of scaffolds 
into the biological environment, when the proteins give signals to the cells’ integrin and 
facilitate cell attachment to the scaffolds’ surface (Chang and Wang, 2011). FBS 
adsorption was investigated at three time points during 24 h by BCA assay (quantitative) 
and SEM (qualitative) to screen the amount and morphology of the proteins on the surface 
of the pores. As shown in Figure 4A, +P samples showed higher protein adsorption 
capacity (70 µg) than -P samples (50 µg). This result can also be observed in SEM images 
in Figure 4B in which bigger protein aggregations are attached on the +P scaffolds 
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matrix, while only protein fibers can be observed on -P samples. This can be due to the 
rougher surface of +P samples, which is caused by PPy web-like fibers. In PBS buffer, 
the adsorption process took place at pH 7.4, which was higher than the isoelectric point 
of BSA (4.8), the main protein of FBS serum. As a consequence, BSA has a negative 
charge in the physiologic pH of the human body. Therefore, it can be absorbed on the 
positive chains of PPy. Overall, PPy created a high porosity, and therefore, high surface 
for proteins to be adsorbed, and also created the suitable charges on the pores to attract 
more proteins (Azioune et al., 2002), which led to higher cell attachment. 
 
3.7. Drug release 
The release of a model antibiotic drug, VCM, from the conductive and non-conductive 
scaffolds was measured during 4 months. First, it was observed that the mesoporous silica 
microparticles were loaded with 6.3% of the drug. During the fabrication of the scaffolds, 
where130 µg/ml of drug was lost during crosslinking process and washing steps. At the 
end, scaffolds were loaded with 2.019 ± 0.1% (+P) and 2.4 ± 0.15% (−P) of drug based 
on scaffolds weight.  
The cumulative release of VCM from both +P and -P composite scaffolds was studied 
during 4 months in PBS, as shown in Figure 5. No rapid or significant burst release was 
observed for both types of scaffolds. After 20 days, the composite scaffolds started to 
reach to a release plateau until almost 80% drug release for +P and 50% for -P scaffolds. 
A higher drug release was observed for the +P samples, which can be due to higher 
surface area and porosity that the web-like fibers provides (Luo and Cui, 2009; Schnieders 
et al., 2011). In addition, VCM is a polycationic antibiotic, which might be detached from 
the positive charges of PPy chains in the +P samples (Azioune et al., 2002; Williams and 
Domen, 1990). As was mentioned in section 3.1, the pore size of the mesoporous silica 
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microparticles (SYLOID® 244 FP) was measured by the BET method, showing an 
average pore diameter size of 19 nm. Limnell et al. reported that the microparticles 
showed faster release of indomethacin compare to MCM-41 silica due to their large pore 
size (Limnell et al., 2011b). In addition, Figure 1B shows the mesoporous silica 
microparticles embedded on the gelatin matrix, suggesting that the loaded VCM might be 
trapped in the gelatin matrix. This also explains why the VCM was not completely 
released. Overall, these scaffold systems were able to avoid the burst release of VCM and 
extended the time of the release in PBS buffer due to the important role of the gelatin 
matrix in controlling the drug release.  
 
3.8. Cell viability  
Cell viability was tested with ATP luminescence assay for +P and −P composite scaffolds, 
and incubated with blank medium during two weeks to check the biocompatibility of 
scaffolds. The luminescence of the lysed cells in incubated mediums was measured and 
compared with luminescence of the lysed cells in fresh medium as a positive control 
(Figure 6). As shown, the scaffold extracted medium did not affect the osteoblast cell 
viability during 14 days compared to the blank medium. Although we can see a decline 
in the cell viability after day 5, the medium which has been extracted from the incubated 
scaffolds did not show toxicity and the cells were viable as in the blank medium. This 
suggests that the degradation of the scaffolds did not hinder the cell proliferation and PPy 
fibers on the matrix did not have any toxic effect on the biocompatibility of the composite 
scaffolds. The viability of the cells remained almost same for both types of scaffolds with 
no significant differences. The results prove the fact that conductive polymer of PPy did 
not show toxicity in +P composite scaffold in the vicinity of osteoblast cells 
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3.9. Cell attachment 
Cell morphology was investigated in vitro in normal medium (non-osteogenic) during 21 
days. Figure 7 shows the interactions of the osteoblast cells and the scaffolds matrices. 
In day 1, cells started to attach on the gelatin matrix and high cell infiltration was observed 
in day 7, as the cells were seen inside the matrix instead of being attached on the surface 
of the scaffolds. As the gelatin tended to swell in the medium, the structure became bigger 
in size and the cells inclined into the scaffolds. The cell infiltration has also been reported 
in hydrogel matrices in some studies (Annabi et al., 2009; Ji et al., 2011). The swelling 
ability of the hydrophilic gelatin assisted the cells to adhere onto the surface of the 
scaffolds and allowed them to enter inside the scaffolds. Overall, the conductive 
composite showed good biocompatibility and provided an appropriate environment for 
the attachment, growth and proliferation of the osteoblast cells.  
 
4. Conclusion 
 
We have shown here that the scaffolds composed of PPy, gelatin, HAp and VCM-loaded 
mesoporous silica microparticles exhibited suitable mechanical properties close to bone 
ones. These novel scaffolds showed compressive strength close to non-conductive 
scaffolds without decreasing the Young's modulus. The porosity and high surface area of 
+P affected the protein adsorption and prolonged the VCM release over time. Web-like 
fibers of PPy on the gelatin matrix played an important role in the surface charge, which 
can affect the release of the drug and adsorption of the proteins. In addition, the 
conductive composite scaffolds promoted the biomineralization and induced the 
formation of CaP crystals faster than the non-conductive composites. The swelling of 
gelatin allowed the matrix of the scaffold to be expanded in the stimulated body fluid or 
cell medium, which makes enough space for the cells to attach and infiltrate into the 
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gelatin. Osteoblast cells were perfectly immersed in the conductive gelatin matrix and 
stayed viable for 14 days. Overall, we demonstrated that PPy could be used in bone tissue 
engineering without any toxic effect on osteoblast cells, while retaining essential 
properties like mechanical strength and create the conductive structure with a potential to 
release drugs during 4 months from a conductive bone scaffold.  
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FIGURE CAPTIONS 
 
Figure 1. (A) Schematic representation of the procedure to fabricate conductive 
scaffolds. Slurry casting method followed by freeze-drying for 48 h and crosslinking with 
8% glutaraldehyde. The samples were washed by distilled water and ethanol to remove 
the remained glutaraldehyde and then dried by freeze-drying method for 6h at −50°C. (B) 
Cross-section SEM images of +P scaffolds, demonstrating interconnected pores. Arrows 
in the magnified image show web-like PPy (red) attached to the gelatin matrix on the 
scaffold. Green arrows are showing mesoporous silica microparticles and blue arrows 
indicate the HAp. (C) FTIR spectra of ball-milled +P and -P scaffolds. Green lines 
correspond to the stretches of Si-O-Si and Si-O bonds responsible for mesoporous silica 
microparticles, blue line shows the PO4 bending of HAp, and orange line shows the bonds 
that correspond to gelatin and yellow line of gelatin and HAp Ca-COO bond. (D) 
TGA/DSC graphs in synthetic air at 20 °C/min for +P and -P samples.  
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Figure 2. (A) Stress-strain curve of +P and -P samples. (B) Water adsorption during 7 
days with over 100% of weight increase for +P and -P samples. Errors bars represent 
mean ± S.D (n = 3). Statistical analysis was made by one-way analysis of variance 
(ANOVA) with the level of significance set at the probability of **p < 0.01. 
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Figure 3. SEM images of CaP localization on the pores of +P and -P samples after 7, 10, 
14 and 21 days of immersion in SBF (5). First CaP crystals can be seen on day 7 in +P 
samples, while the -P surface showed no crystal formation. After 10 days, samples were 
covered by non-confluent multilayers of CaP. These layers became confluent over time 
until day 21, which resulted in multilayered confluent CaP coating. Scale bares are 20 
µm. Energy-dispersive X-ray spectroscopy (EDX) on the right side of each SEM image 
shows the main peaks of Ca and P.  The Si peak disappeared from day 10 onwards due to 
the whole coverage of CaP on the pores of the scaffolds.  
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Figure 4. FBS proteins adsorption during 24 h. (A) Quantitative FBS concentration after 
4, 14 and 24 h of incubation in PBS+10% FBS solution at 37 °C. Errors bars represent 
mean ± S.D (n = 3). Statistical analysis was made by one-way analysis of variance 
(ANOVA) with the level of significance set at probabilities of *p < 0.05 and **p < 0.01. 
(B) SEM imaging of scaffolds after 4, 14 and 24 h of incubation in PBS+10% FBS 
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solution at 37 °C, showing the morphology of the attached proteins on the pores. Scale 
bars are 50 µm.  
 
 
Figure 5. The cumulative release of VCM from +P and -P scaffolds (n = 4) immersed in 
PBS pH 7.4 for 4 months at 37 °C. The +P samples released almost 80% of VCM, while 
the maximum release for -P samples was around 50%. Statistical analysis was made by 
AC
CE
PT
ED
 M
AN
US
CR
IPT
32 
 
one-way analysis of variance (ANOVA) with the level of significance set at the 
probability of *p < 0.05. 
 
 
Figure 6. The viability of osteoblast cells in medium extracted from +P and −P scaffolds, 
and incubated with blank medium for two weeks compared with fresh medium (positive 
control) and Triton X-100 (negative control), which is represented by measuring ATP 
luminescence. Errors bars represent mean ± S.D (n = 4). Statistical analysis was achieved 
by means of one-way analysis of variance (ANOVA) with the level of significance set at 
probabilities of *p < 0.05, **p < 0.01 and ***p < 0.001.  AC
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Figure 7. Cell infiltration after 1, 7, 14 and 21 days of immersing the scaffolds (+P and 
−P samples) in normal medium with 10% FBS. The cells on +P samples in day 7 spread 
on the matrix with elongated shape. Arrows show the cells that are covered by crystals 
produced in the medium. Scale bars are 20 µm. 
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